Il y a eu 50 transactions d'initiés récentes enregistrées pour Talis Biomedical Corporation (TLIS), dont 37 achats et 5 ventes. Le total des achats d'initiés s'élève à $12.33M et le total des ventes d'initiés à $47.41K.
Les initiés notables ayant une activité récente comprennent Leonard Braden Michael, Young John T. Jr., Ferrari Patricia. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — TLIS
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-09-06 |
Leonard Braden Michael |
10 Percent Owner |
Achat Informatif |
25,000 |
$1.48 |
$37.1K |
248,702 |
| 2024-09-05 |
Leonard Braden Michael |
10 Percent Owner |
Achat Informatif |
5,100 |
$1.40 |
$7.14K |
223,702 |
| 2024-09-03 |
Leonard Braden Michael |
10 Percent Owner |
Achat Informatif |
500 |
$4.00 |
$2K |
218,602 |
| 2024-08-30 |
Leonard Braden Michael |
10 Percent Owner |
Achat Informatif |
151 |
$4.25 |
$641.75 |
218,602 |
| 2024-08-28 |
Leonard Braden Michael |
10 Percent Owner |
Achat Informatif |
1,215 |
$3.96 |
$4.81K |
217,951 |
| 2024-08-26 |
Leonard Braden Michael |
10 Percent Owner |
Achat Informatif |
13,167 |
$3.90 |
$51.32K |
216,736 |
| 2024-08-14 |
Leonard Braden Michael |
10 Percent Owner |
Inconnu |
- |
- |
- |
203,569 |
| 2024-07-31 |
Young John T. Jr. |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-07-31 |
Ferrari Patricia |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-08-01 |
Lukowiak Andrew A |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-08-01 |
Lukowiak Andrew A |
President |
Attribution de RSU |
30,575 |
$7.42 |
$226.87K |
30,575 |
| 2023-07-17 |
Markovich Rebecca |
Interim CFO |
Attribution de RSU |
13,071 |
$7.65 |
$99.99K |
13,071 |
| 2023-06-09 |
Popovits Kimberly J |
Director |
Attribution de RSU |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Scott Randal W. |
Director |
Attribution de RSU |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Dreismann Heinrich |
Director |
Attribution de RSU |
5,466 |
$0.50 |
$2.73K |
5,466 |
| 2023-06-09 |
Posard Matthew L. |
Director |
Attribution de RSU |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Ismagilov Rustem F. |
Director |
Attribution de RSU |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Gilliam Melissa |
Director |
Attribution de RSU |
95,000 |
$0.50 |
$47.5K |
95,000 |
| 2023-06-09 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Attribution de RSU |
23,685 |
$0.50 |
$11.95K |
23,685 |
| 2023-05-19 |
Dreismann Heinrich |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-05-19 |
Dreismann Heinrich |
Director |
Attribution de RSU |
190,000 |
$0.46 |
$87.4K |
190,000 |
| 2023-04-21 |
Markovich Rebecca |
Interim CFO |
Cession |
70,000 |
$0.49 |
$34.3K |
- |
| 2023-04-07 |
Moody John Roger Jr |
Chief Financial Officer |
Attribution de RSU |
300,000 |
$0.49 |
$147K |
300,000 |
| 2023-04-07 |
Kelley Robert J. |
Chief Executive Officer |
Attribution de RSU |
500,000 |
$0.49 |
$245K |
500,000 |
| 2023-03-10 |
Cheong Raymond |
Director |
Inconnu |
- |
- |
- |
- |
| 2022-06-10 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Attribution de RSU |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Popovits Kimberly J |
Director |
Attribution de RSU |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Scott Randal W. |
Director |
Attribution de RSU |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Baker Brothers Life Sciences Lp |
Director |
Attribution de RSU |
95,000 |
- |
- |
95,000 |
| 2022-06-10 |
Posard Matthew L. |
Director |
Attribution de RSU |
95,000 |
$1.00 |
$95K |
95,000 |
| 2022-06-10 |
Ismagilov Rustem F. |
Director |
Attribution de RSU |
95,000 |
- |
- |
95,000 |
| 2022-06-10 |
Gilliam Melissa |
Director |
Attribution de RSU |
95,000 |
- |
- |
95,000 |
| 2022-06-01 |
Moody John Roger Jr |
Chief Financial Officer |
Attribution de RSU |
500,000 |
- |
- |
500,000 |
| 2022-06-01 |
Kelley Robert J. |
Chief Executive Officer |
Attribution de RSU |
723,560 |
- |
- |
723,560 |
| 2021-12-08 |
Kelley Robert J. |
Chief Executive Officer |
Attribution de RSU |
450,000 |
$4.28 |
$1.93M |
450,000 |
| 2021-12-01 |
Blaser Brian J |
President and CEO |
Inconnu |
- |
- |
- |
- |
| 2021-12-01 |
Blaser Brian J |
President and CEO |
Attribution de RSU |
625,000 |
- |
- |
625,000 |
| 2021-11-18 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Achat Informatif |
50,000 |
$4.37 |
$218.25K |
7,053,176 |
| 2021-10-02 |
Moody John Roger Jr |
Chief Financial Officer |
Attribution de RSU |
130,000 |
$6.17 |
$802.1K |
579,897 |
| 2021-10-02 |
Liu Douglas |
Chief Operating Officer |
Attribution de RSU |
200,000 |
$6.17 |
$1.23M |
514,685 |
| 2021-10-02 |
Kelley Robert J. |
Chief Commercial Officer |
Attribution de RSU |
130,000 |
$6.17 |
$802.1K |
427,202 |
| 2021-08-30 |
Popovits Kimberly J |
Interim CEO |
Attribution de RSU |
550,000 |
$9.06 |
$4.98M |
550,000 |
| 2021-08-13 |
Ramakrishnan Ramesh |
Officer |
Exercice d'Options (Vente) |
8,741 |
$1.50 |
$13.11K |
- |
| 2021-05-17 |
Scott Randal W. |
Director |
Achat Informatif |
11,000 |
$10.11 |
$111.21K |
20,000 |
| 2021-05-14 |
Scott Randal W. |
Director |
Achat Informatif |
9,000 |
$10.16 |
$91.44K |
9,000 |
| 2021-03-16 |
Hilleman Jeryl L |
Director |
Inconnu |
- |
- |
- |
- |
| 2021-03-16 |
Hilleman Jeryl L |
Director |
Attribution de RSU |
35,112 |
$17.60 |
$617.97K |
35,112 |
| 2021-02-17 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Exercice d'Options (Vente) |
10,214,159 |
- |
- |
- |
| 2021-02-17 |
Popovits Kimberly J |
Director |
Conversion (Vente) |
128,655 |
- |
- |
- |
| 2021-02-17 |
Scott Randal W. |
Director |
Conversion (Vente) |
432,749 |
- |
- |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi